Dynamic monitoring serum tumor markers to predict molecular features of <scp>EGFR</scp> ‐mutated lung cancer during targeted therapy-Reference-Cited by-同舟云学术

Dynamic monitoring serum tumor markers to predict molecular features of EGFR ‐mutated lung cancer during targeted therapy

Published:2022-05-11 Issue:16 Volume:11 Page:3115-3125
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Chen Zhuxing¹^ORCID,Liu Liping¹,Zhu Feng¹,Cai Xiuyu²,Zhao Yi¹,Liang Peng¹,Ou Limin¹,Zhong Ran¹,Yu Ziwen¹,Li Caichen¹,Li Jianfu¹,Xiong Shan¹^ORCID,Feng Yi¹^ORCID,Cheng Bo¹,Liang Hengrui¹,Xie Zhanhong³,Liang Wenhua¹,He Jianxing¹^ORCID

Affiliation:

1. Department of Thoracic Surgery/Oncology, China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease the First Affiliated Hospital of Guangzhou Medical University Guangzhou China

2. Department of General Internal Medicine, Sun Yat‐sen University Cancer Centre, State Key Laboratory of Oncology in South China Collaborative Innovation Centre for Cancer Medicine Guangzhou China

3. Department of Respiratory Disease, China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease the First Affiliated Hospital of Guangzhou Medical University Guangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4676

Reference47 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. New and emerging targeted treatments in advanced non-small-cell lung cancer

3. Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer